Patients with depression have higher levels of biomarkers that promote atherosclerosis; in anxiety and depression, we see reduced heart rate variability, suggesting decreased parasympathetic activity, altered serotonergic pathways, altered platelet aggregability, and increased C-reactive protein, an indicator of increased inflammatory response. This evidence concerns the gene CRP and depressive symptom measurement.